Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,200
Avg Vol 84,906
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 42%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprisin...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 613-241-9959
Address:
429 Kent Street unit 112, Ottawa, Canada
Latest News on CTTH
No data available.